Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Orthocell.
RELATED STOCKHEAD STORIES
Stockhead TV
Long Shortz with Orthocell: Nerve repair product ready for US domination on $17M raise
Health & Biotech
Orthocell placement to raise $17m for US and global launch for collagen nerve wrap
Health & Biotech
ASX Quarterly Health Wrap: Regulatory wins and record revenue
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX innovators reshaping traditional medical treatments
Stockhead TV
Long Shortz with Orthocell: Gateway to Asia open with Singapore market entry
Health & Biotech
Biocurious: With Singaporean approval ticked off, Orthocell eyes the crucial US nerve-repair market
Health & Biotech
Orthocell secures regulatory approval to launch Remplir sales in Singapore
Health & Biotech
Health Check: Lion City’s Orthocell approval provides a Singapore Sling-board to Asian markets
Health & Biotech
Orthocell delivers second quarter of record revenue
News
Closing Bell: Arcadium soars 47pc as Rio makes move; retailers beg RBA to cut rates before Christmas
Health & Biotech
Health Check: Long-suffering Mesoblast investors dare to dream
Health & Biotech
ASX health stocks capitalise on growing Southeast Asian market
Health & Biotech
Bio Curious: Nerve repair house plans to break the IPO drought
Health & Biotech
Orthocell’s collagen-membrane dental-regeneration product Striate+ debuts in Canada
Stockhead TV
Break it Down: Orthocell smiles on key sales
Stockhead TV
